Aytu BioPharma, Inc. - Common Stock — Cash Flow (NASDAQ:AYTU) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Cash from operating activities -25.96 M-28.82 M-5.13 M-1.39 M-1.94 M3.28 M 3.28 M Cash from investing activities -2.78 M-3.25 M-117 K-329 K-2.56 M-29 K -29 K Cash from financing activities 30.31 M1.53 M8.87 M-1.26 M15.44 M-7.9 M -7.9 M Free cash flow -25.96 M-28.82 M-5.13 M-1.39 M-1.94 M3.25 M 3.25 M

News

Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?

Microsoft To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday

Ascendiant Capital Maintains Buy on Aytu BioPharma, Raises Price Target to $15

Transcript: Aytu BioPharma Q4 2026 Earnings Conference Call

Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates

Aytu BioPharma Q4 EPS $0.00 and Sales $16.106M Beat $12.276M Estimate

Earnings Scheduled For September 22, 2026

HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates

New Strong Sell Stocks for July 20th

New Strong Sell Stocks for July 16th

Aytu BioPharma, Inc. (AYTU) Q3 2026 Earnings Call Transcript

Aytu BioPharma, Inc. (AYTU) Reports Q3 Loss, Tops Revenue Estimates